- Home
- Find a Researcher
- Howard Katzenstein, MD
Howard Katzenstein, MD
Division Chief - Hematology/Oncology
Nemours Children's Health, Jacksonville
807 Children's Way
Jacksonville,
FL
32207
Education & Training
Fellowship
Pediatric Hematology/Oncology - Ann & Robert H. Lurie Children's Hospital, 1997
Internship Residency
Pediatrics - Childrens Hospital of Pittsburgh UPMC, 1994
- Cancer Biomarkers and Therapeutics
- Hematology
- Oncology
- Katzenstein, H. M., Malogolowkin, M. H., Krailo, Piao, J., Towbin, A. J., McCarville, M. B., & Meyers, R. L. (2022). Doxorubicin in combination with cisplatin, 5-flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group study. Cancer, 128(5), 1057-1065. doi:10.1002/cncr.34014
View Full Publication - Trobaugh-Lotrario, A., Katzenstein, H. M., Ranganathan, S., Lopez-Terrada, D., Krailo, Piao, J., & Finegold, M. J. (2022). Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report from the Children's Oncology Group (COG) AHEP0731 Study Committee. Journal of Clinical Oncology, 40(5), 459-467. doi:10.1200/JCO.21.00803
View Full Publication - Katzenstein, H. M., Malogolowkin, M. H., Krailo, Piao, J., Towbin, A. J., McCarville, M. B., & Meyers, R. L. (2022). Doxorubicin in combination with cisplatin, 5-flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group study. Cancer, 128(5), 1057-1065. doi:10.1002/cncr.34014
View Full Publication - Katzenstein, H. M., Malogolowkin, M. H., Krailo, Piao, J., Towbin, A. J., McCarville, M. B., & Meyers, R. L. (2022). Doxorubicin in combination with cisplatin, 5-flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group study. Cancer, 128(5), 1057-1065. doi:10.1002/cncr.34014
- Katzenstein, H. M., Aguado, A., Cheek, B., & Gresh, R. (2021). Neonatal Liver Tumors. Clinics in Perinatology, 48(1), 83-99. doi:10.1016/j.clp.2020.11.005
View Full Publication - Hoppe, B. S., Mailhot Vega, R. B., Mendenhall, N. P., Sandler, E. S., Slayton, W. B., Katzenstein, H., & Flampouri, S. (2021). Irradiating residual disease to 30 Gy with proton therapy in pediatric mediastinal Hodgkin lymphoma. International Journal of Particle Therapy, 6(4), 11-16. doi:10.14338/IJPT-19-00077.1
- Klawinski, D., Hanna, I., Breslin, N. K., Katzenstein, H. M., & Indelicato, D. J. (2021). Vaping the venom: Oral cavity cancer in a young adult with extensive electronic cigarette use. Pediatrics, 147(5). doi:10.1542/peds.2020-022301
View Full Publication - Chellapandian, D., Sunkersett, G., Oshrine, B., Galvez Silva, J., Ziga, E., Alperstein, W., & Horn, B. (2021). Pediatric HCT in Florida (2014 -2016): A report from the FPBCC. Pediatric Transplantation, 25(5). doi:10.1111/petr.13931
View Full Publication - Seligson, N. D., Maradiaga, R. D., Stets, C. M., Katzenstein, H. M., Millis, S. Z., Rogers, A., & Chen, J. L. (2021). Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target. npj Precision Oncology, 5(1). doi:10.1038/s41698-021-00177-0
- Katzenstein, H. M., Malogolowkin, M. H., Krailo, Piao, J., Towbin, A. J., McCarville, M. B., & Meyers, R. L. (2022). Doxorubicin in combination with cisplatin, 5-flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group study. Cancer, 128(5), 1057-1065. doi:10.1002/cncr.34014
- Aguado, A., Dunn, S. P., Averill, L. W., Chikwava, K. R., Gresh, R., Rabinowitz, D., & Katzenstein, H. M. (2020). Successful use of transarterial radioembolization with yttrium-90 (TARE-Y90) in two children with hepatoblastoma. Pediatric Blood and Cancer, 67(9). doi:10.1002/pbc.28421
View Full Publication - Cash, T., Bettermann, E. L., Mitchell, S., McCracken, C., Qayed, M., Wolfe, D., & Katzenstein, H. M. (2020). Routine Surveillance Imaging Is Associated with Improved Postrelapse Survival in Patients with Ewing Sarcoma. Journal of Adolescent and Young Adult Oncology, 9(3), 394-401. doi:10.1089/jayao.2019.0131
View Full Publication - Mody, R., Yu, A. L., Naranjo, A., Zhang, F. F., London, W. B., Shulkin, B. L., & Bagatell, R. (2020). Irinotecan, temozolomide, and dinutuximab with GM-CSF in children with refractory or relapsed neuroblastoma: A report from the children's Oncology group. Journal of Clinical Oncology, 38(19), 2160-2169. doi:10.1200/JCO.20.00203
View Full Publication - Qayed, M., Cash, T., Tighiouart, M., MacDonald, T. J., Goldsmith, K. C., Tanos, R., & Katzenstein, H. M. (2020). A phase I study of sirolimus in combination with metronomic therapy (CHOAnome) in children with recurrent or refractory solid and brain tumors. Pediatric Blood and Cancer, 67(4). doi:10.1002/pbc.28134
View Full Publication - Weldon, C. B., Madenci, A. L., Tiao, G. M., Dunn, S. P., Langham, M. R., McGahren, E. D., & Katzenstein, H. M. (2020). Evaluation of the diagnostic biopsy approach for children with hepatoblastoma: A report from the children's oncology group AHEP 0731 liver tumor committee. Journal of Pediatric Surgery, 55(4), 655-659. doi:10.1016/j.jpedsurg.2019.05.004
View Full Publication - Uezono, H., Indelicato, D. J., Rotondo, R. L., Sandler, E. S., Katzenstein, H. M., Dagan, R., & Bradley, J. A. (2019). Proton therapy following induction chemotherapy for pediatric and adolescent nasopharyngeal carcinoma. Pediatric Blood and Cancer, 66(12). doi:10.1002/pbc.27990
View Full Publication - Katzenstein, H. M., Langham, M. R., Malogolowkin, M. H., Krailo, Towbin, A. J., McCarville, M. B., & Meyers, R. L. (2019). Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial. The Lancet Oncology, 20(5), 719-727. doi:10.1016/S1470-2045(18)30895-7
View Full Publication - Twist, C. J., Schmidt, M. L., Naranjo, A., London, W. B., Tenney, S. C., Marachelian, A., & Cohn, S. L. (2019). Maintaining outstanding outcomes using response- And biology-based therapy for intermediate-risk neuroblastoma: A report from the children's oncology group study ANBL0531. Journal of Clinical Oncology, 37(34), 3243-3255. doi:10.1200/JCO.19.00919
View Full Publication - Kalapurakal, J. A., Gopalakrishnan, M., Walterhouse, D. O., Rigsby, C. K., Rademaker, A., Helenowski, I., & Fitzgerald, T. J. (2019). Cardiac-Sparing Whole Lung IMRT in Patients With Pediatric Tumors and Lung Metastasis: Final Report of a Prospective Multicenter Clinical Trial. International Journal of Radiation Oncology Biology Physics, 103(1), 28-37. doi:10.1016/j.ijrobp.2018.08.034
View Full Publication - Katzenstein, H. M., Furman, W. L., Malogolowkin, M. H., Krailo, McCarville, M. B., Towbin, A. J., & Meyers, R. L. (2017). Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee. Cancer, 123(12), 2360-2367. doi:10.1002/cncr.30591
View Full Publication
Choose a Region
Nemours has a number of service regions. Selecting your region will help us show you the right contact information and the most relevant content for you.